Award recordCONTRACT

ALEXION PHARMACEUTICALS INC

PIID 36C26025F0093· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2025· $626,866 net obligations· UEI DKCXLGANZAN3· CT

Description

STRENSIQ - DECREASE IN FSS PRICE

Base award description: STRENSIQ

First action · last action
2024-12-20 · 2026-04-02
Transactions
3
First transaction's obligation
$1,253,970
Base + all options value (sum of deltas)
$626,866
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79718D0355
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1,253,970$0Base award · 2024-12-20 · this action $1,253,970 · running total $1,253,970Modification P00001 · 2025-08-05 · this action -$297 · running total $1,253,673Modification P00002 · 2026-04-02 · this action -$626,807 · running total $626,866
  • Base2024-12-20+$1,253,970= $1,253,970
  • Mod P000012025-08-05-$297= $1,253,673
  • Mod P000022026-04-02-$626,807= $626,866
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-12-20+$1,253,970$1,253,970STRENSIQ
Mod P00001· FUNDING ONLY ACTION2025-08-05−$297$1,253,673STRENSIQ - DECREASE IN FSS PRICE
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-04-02−$626,807$626,866STRENSIQ - DECREASE IN FSS PRICE

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DKCXLGANZAN3)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24526N0739245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$104,650FY2026
36F79726D0143NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0055260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$1,255,805FY2026
36C26024F0096260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$522,487FY2024
36C26024F0071260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$187,948FY2024

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26025F0093_3600_36F79718D0355_3600 · retrieved 2026-09-26.